You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
皓元醫藥(688131.SH):已與AI製藥公司德睿智藥、臨牀階段生物醫藥公司英矽智能等形成戰略合作
格隆匯 03-20 16:25

格隆匯3月20日丨皓元醫藥(688131.SH)在投資者互動平台表示,人工智能可基於已有分子結構及活性,通過自動學習,總結提取化合物分子規律,從而生成很多自然界從未存在過的化合物作為候選藥物分子,構建擁有一定規模且高質量的分子庫,拓展化學空間,為藥物研發提供更多先導化合物。目前公司已與AI製藥公司德睿智藥、臨牀階段生物醫藥公司英矽智能等形成戰略合作,通過AI模式助力新藥研發突破技術壁壘,推進人工智能在藥物研發階段的應用落地。未來公司將繼續深化合作,加快一站式化合物合成路線預測和推薦平台的數字化進程,持續提升化合物篩選的質量和效率,助力新藥研發。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account